Which stocks have an unusual volume on Friday? Let's explore the current happenings on the US markets on Friday. Below, you'll find the stocks exhibiting unusual volume in today's session.
US Stocks Likely To Open On A Mixed Note: 'Nothing Good Happens Above A 5% Yield,' Says Expert U.S. stock futures were fluctuating on Friday after a mixed close on Thursday. Futures of benchmark indices were mixed in premarket.
Sanofi Inks A $470 Million Alzheimer's Deal, Sending This Dollar Stock Flying The company is working on an Alzheimer's treatment that increases the activity of TREM2, a neuroinflammation target.
Vigil Neuroscience Stock Triples Pre-market On Acquisition By Sanofi: Retail Goes Super Bullish Under the terms of the deal, Sanofi will acquire all outstanding common shares of Vigil for $8 per share in cash at closing.
Sanofi Boosts Alzheimer's Pipeline With Vigil Neuroscience Acquisition Sanofi (SNY) to acquire Vigil Neuroscience (VIGL) for $470 million in cash, plus potential $2 per share payout. Acquisition excludes monoclonal antibody program and is expected to be finalized in Q3 2025. VG-3927 showed promise in Phase 1 for Alzheimer's treatment.
Here are the top movers in Thursday's session. Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Vigil Neuroscience's Alzheimer's Candidate Shows Encouraging Safety Profile, Plans To Start Mid-Stage Study In Q3 Vigil Neuroscience's VG-3927 Phase 1 trial shows strong safety, 50% sTREM2 reduction, and potential Alzheimer's treatment; Phase 2 begins Q3 2025.
VIGL Stock Earnings: Vigil Neuroscience Beats EPS for Q2 2024 VIGL stock results show that Vigil Neuroscience beat analyst estimates for earnings per share the second quarter of 2024.
Small Neurodegenerative Disease-Focused Vigil Neuroscience Says Alzheimer's Candidate Shows Significant Impact On Disease Bimarker Vigil Neuroscience reports promising interim results from its Phase 1 trial of VG-3927, showing a strong safety, tolerability, and pharmacokinetic profile in healthy volunteers. The data support continued development of VG-3927 as a potential daily oral therapy for Alzheimer's disease.
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 33% Today? Tonix Pharmaceuticals stock is falling on Thursday after the company announced a proposed public offering for shares of TNXP.
Why Is Branchout Food (BOF) Stock Down 39% Today? Branchout Food stock is down on Thursday after the company priced an offering of 1.75 million shares of BOF at 80 cents each.
Why Is Vigil Neuroscience (VIGL) Stock Up 32% Today? Vigil Neuroscience stock is up with heavy trading of VIGL shares this morning on news of a $40 million investment from Sanofi.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday Pre-market stock movers are worth checking out on Thursday as we dig into all of the biggest news moving shares this morning!
3 Penny Stocks With the Power to 10X Your $1k Investment: June Edition Penny stocks are risky because of their insane volatility — but these have a chance to 10x your investments.
